Incyte Corp. (INCY)
124.44
-0.20
(-0.16%)
USD |
NASDAQ |
Sep 24, 16:00
124.41
-0.03
(-0.02%)
After-Hours: 19:59
Incyte Gross Profit (Annual) : 4.703B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.703B |
| December 31, 2024 | 3.864B |
| December 31, 2023 | 3.380B |
| December 31, 2022 | 3.141B |
| December 31, 2021 | 2.799B |
| December 31, 2020 | 2.505B |
| December 31, 2019 | 2.011B |
| December 31, 2018 | 1.754B |
| December 31, 2017 | 1.426B |
| December 31, 2016 | 1.002B |
| December 31, 2015 | 704.34M |
| December 31, 2014 | 467.08M |
| December 31, 2013 | 325.11M |
| December 31, 2012 | 266.92M |
| December 31, 2011 | 67.46M |
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.00 |
| December 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
| December 31, 1995 | 0.00 |
| December 31, 1994 | 0.00 |
| December 31, 1993 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 11.70B |
| AbbVie, Inc. | 42.89B |
| Biogen, Inc. | 6.454B |
| Eli Lilly & Co. | 54.13B |
| ACADIA Pharmaceuticals, Inc. | 971.62M |